In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main ProteaseArticle Published on 2024-06-252024-09-05 Journal: Biomolecules [Category] update2024, [키워드] Ivermectin main protease (Mpro) molecular docking molecular dynamics Nirmatrelvir SARS-CoV-2 [DOI] 10.3390/biom14070755 PMC 바로가기 [Article Type] Article
Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometryResearch Article Published on 2024-04-152024-09-05 Journal: Heliyon [Category] update2024, [키워드] Doramectin Ivermectin LC-MS/MS onchocerciasis VAMS [DOI] 10.1016/j.heliyon.2024.e29606 PMC 바로가기 [Article Type] Research Article
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesArticle Published on 2024-04-012024-09-05 Journal: The Journal of infection [Category] update2024, [키워드] clinical trial COVID-19 Ivermectin long-term follow up SARS-CoV2 [DOI] 10.1016/j.jinf.2024.106130 PMC 바로가기 [Article Type] Article
Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic TherapyPreventive Medicine Published on 2024-03-122024-09-05 Journal: Cureus [Category] update2024, [키워드] anti-cancer Anti-inflammatory anti-parasitic Anti-viral Ivermectin malaria nuclear factor kappa-light-chain enhancer of activated b cells (nf-κb) [DOI] 10.7759/cureus.56025 PMC 바로가기 [Article Type] Preventive Medicine
Ivermectin for treatment of COVID-19: A systematic review and meta-analysisResearch Article Published on 2024-03-112024-09-05 Journal: Heliyon [Category] update2024, [키워드] COVID-19 Ivermectin Meta-analysis SARS-CoV-2 Treatment [DOI] 10.1016/j.heliyon.2024.e27647 PMC 바로가기 [Article Type] Research Article
Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proofResearch Published on 2024-03-072024-09-05 Journal: BMC Chemistry [Category] update2024, [키워드] COVID-19 Drug-drug interactions fluvoxamine green Insilico Ivermectin Repurposed Spectrophotometry synchronous [DOI] 10.1186/s13065-024-01147-w PMC 바로가기 [Article Type] Research
Use of ivermectin and factors associated with the prevention and/or treatment of COVID-19: a cross-sectional online survey in the province of Chincha, PeruResearch Article Published on 2024-01-082024-09-05 Journal: F1000Research [Category] update2024, [키워드] COVID-19 Ivermectin Peru Treatment and Prevention [DOI] 10.12688/f1000research.128675.3 PMC 바로가기 [Article Type] Research Article
Exposures to Bleach, Peroxide, Disinfectants, Antimalarials, and Ivermectin Reported to the California Poison Control System Before and During the COVID-19 Pandemic, 2015-2021Research Published on 2023-11-072024-09-05 Journal: Public health reports (Washington, D.C. : 1974) [Category] update2024, [키워드] Antimalarials bleach Chloroquine COVID-19 Disinfectants household cleaning products Hydroxychloroquine Ivermectin peroxide [DOI] 10.1177/00333549231201679 PMC 바로가기 [Article Type] Research
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label usearticle Published on 2023-10-312024-09-05 Journal: Parasites & Vectors [Category] update2024, [키워드] Acedapsone albendazole amoxicillin Artemether artemisinins Arterolane artesunate Azithromycin azoles Balapiravir celgosivir Chloroquine clarithromycin Clavulanate CURE ID dapsone Diethylcarbamazine disulfiram doxycycline Drug reprofiling Drug repurposing fluconazole Imatinib Isavuconazonium itraconazole Ivermectin ketoconazole Levamisole Lumefantrine Mebendazole mefloquine Moxidectin moxifloxacin Neglected topical diseases nitazoxanide off-label use Oxamniquine Oxantel Piperaquine Posaconazole Praziquantel Pyrantel pamoate ravuconazole ribavirin rifampicin Rifapentine Sparfloxacin streptomycin Tribendimidine UV-4B [DOI] 10.1186/s13071-023-05909-8 PMC 바로가기 [Article Type] article
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospitalArtículo Original Published on 2023-03-282024-09-05 Journal: Revista peruana de medicina experimental y salud pública [Category] update2024, [키워드] Azithromycin Azitromicina COVID-19 Farmacovigilancia Hidroxicloroquina Hydroxychloroquine Ivermectin Ivermectina pharmacovigilance Tocilizumab [DOI] 10.17843/rpmesp.2023.401.11563 PMC 바로가기 [Article Type] Artículo Original